US Patent 7943137 FPRL1 ligands and use thereof
Patent 7943137 was granted and assigned to Takeda Pharmaceutical Company on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+286 characters)
Article
Patent abstract
By using FPRL1 ligand, which comprises the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 17 or SEQ ID NO: 21, and FPRL1, an efficient screening for FPRL1 agonist or FPRL1 antagonist can be performed.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Hiromi Yoshida0
Kazunori Nishi0
Makoto Kobayashi0
Masataka Harada0
Shoichi Ohkubo0
Shuji Hinuma0
Yugo Habata0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07943137 FPRL1 ligands and use thereof US Patent 7943137 FPRL1 ligands and use thereof
Infobox
Patent Number
079431370
Patent Number
79431370
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079431370
Date of Patent
May 17, 2011
0Patent Application Number
105340820
Date Filed
November 6, 2003
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07943137 FPRL1 ligands and use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07943137
Date of patent
May 17, 2011
Patent application number
10534082
Date Filed
November 6, 2003
Patent primary examiner
Find more entities like US Patent 7943137 FPRL1 ligands and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
